Relation of Residual Mitral Regurgitation and Gradient Following Mitral Valve Transcatheter Edge-to-Edge Repair

Donika Mustafa1,2, Jennifer von Stein1,3,2, Lukas Stolz4,5

  • 1Department of Cardiology, Heart Center, Faculty of Medicine, University of Cologne, Germany (D.M., J.S., H.G., S.B., R.P., V.M., P. von Stein).

Abstract

Insights

Residual mitral regurgitation (rMR) ≤1+ after PASCAL transcatheter edge-to-edge repair is linked to better 1-year survival. Mildly elevated mitral pressure gradients (MPG) may be acceptable with optimal rMR, but warrant monitoring.

Area of Science:

  • Cardiovascular Medicine
  • Interventional Cardiology
  • Cardiac Surgery

Background:

  • Residual mitral regurgitation (rMR) ≤1+ is linked to improved outcomes post-transcatheter edge-to-edge repair (TEER).
  • Previous studies focused on MitraClip and limited follow-up durations.
  • The association of discharge rMR and mean mitral pressure gradient (MPG) with outcomes after PASCAL TEER is not well-established.

Purpose of the Study:

  • To evaluate the association of discharge residual mitral regurgitation (rMR) and mean mitral pressure gradient (MPG) with 1-year mortality after PASCAL mitral valve transcatheter edge-to-edge repair (TEER).

Main Methods:

  • The REPAIR registry analyzed 2172 patients undergoing PASCAL TEER.
  • Patients were stratified into four groups based on discharge rMR (≤1+ vs. ≥2+) and MPG (<5 mmHg vs. ≥5 mmHg).
  • The primary endpoint was 1-year mortality.

Main Results:

  • One-year mortality varied significantly across groups (P<0.001), lowest in optimal (rMR ≤1+, MPG <5 mmHg) and highest in dual-suboptimal (rMR ≥2+, MPG ≥5 mmHg) groups.
  • rMR ≤1+ was independently associated with lower 1-year mortality (HR 0.54; P<0.001).
  • MPG was not independently associated with mortality when dichotomized (P=0.078), but continuous MPG showed association (HR 1.10 per mmHg; P=0.048), with a trend after adjusting for rMR (aHR 1.07; P=0.145).

Conclusions:

  • Discharge rMR ≤1+ is an independent predictor of lower 1-year mortality following PASCAL TEER.
  • While MPG was not independently associated, elevated gradients may be acceptable with optimal rMR but require clinical attention.

Related Concept Videos

Mitral Regurgitation III: Medical Management01:25

Mitral Regurgitation III: Medical Management

Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
268
Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
402
Mitral Regurgitation II: Clinical Features and Diagnostic Tests01:23

Mitral Regurgitation II: Clinical Features and Diagnostic Tests

Mitral regurgitation (MR) is a valvular heart disorder in which the mitral valve fails to close tightly, allowing blood to leak backward into the heart. Understanding the clinical manifestations, assessment, diagnostic findings, and medical management of MR is crucial to effectively managing affected patients.Clinical Manifestations of Mitral RegurgitationMitral regurgitation can be acute or chronic, each presenting differently and requiring different approaches:1. Acute Mitral...
356
Mitral Regurgitation IV: Nursing Management01:28

Mitral Regurgitation IV: Nursing Management

Mitral regurgitation (MR) is a condition where the mitral valve does not close properly, leading to the backward flow of blood from the left ventricle into the left atrium during systole. This condition can arise from various causes, including rheumatic fever, infective endocarditis, or degenerative valve disease. Effective nursing management is crucial to optimizing patient outcomes and involves comprehensive assessment and targeted interventions.Comprehensive Patient AssessmentA detailed...
300
Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
213
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
239